The effect of local infiltration of tranexamic acid in orthognathic surgery remains unclear. This study was conducted to evaluate the difference in postoperative blood loss, measured by surgical drain output, following orthognathic surgery. The investigation involved a within-subject comparison, where each side of the mandible received a different local anesthetic solution: one side was infiltrated with a mixture of lidocaine with adrenaline and tranexamic acid, while the other side received lidocaine with adrenaline and normal saline.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
25
A local anesthetic solution was prepared by mixing 10 ml of 1% lidocaine with adrenaline (1:100,000) and 5 ml of tranexamic acid (50 mg/ml), resulting in a total volume of 15 ml. The solution was injected at the planned mandibular osteotomy sites on both the medial and lateral aspects of the ramus of the mandible. The injection was administered after completion of general anesthesia, followed by a 5-minute waiting period to allow the anesthetic to take effect before the surgical incision was made.
A local anesthetic solution was prepared by mixing 10 ml of 1% lidocaine with adrenaline (1:100,000) and 5 ml of normal saline (NSS), resulting in a total volume of 15 ml. The solution was injected at the planned mandibular osteotomy sites on both the medial and lateral aspects of the ramus of the mandible. The injection was administered after the induction of general anesthesia, followed by a 5-minute waiting period to allow the anesthetic to take effect before making the surgical incision.
A local anesthetic solution was prepared by mixing 10 ml of 1% lidocaine with adrenaline (1:100,000) and 5 ml of normal saline (NSS) or 5 ml of tranexamic acid (50 mg/ml) depends on allocated group, resulting in a total volume of 15 ml. The solution was injected at the planned mandibular osteotomy sites on both the medial and lateral aspects of the ramus of the mandible. The injection was administered after the induction of general anesthesia, followed by a 5-minute waiting period to allow the anesthetic to take effect before making the surgical incision.
Department of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Bangkok, Bangkok, Thailand
Postoperative blood loss
Amount of surgical drain output
Time frame: 24 hours and 48 hours after the end of intervention
Postoperative pain score
Visual analog scale (0-10) 0 = no pain, 10 = the worst pain
Time frame: 24 hours and 48 hours after the end of intervention
Postoperative edema
Standardized frontal facial photographs to determine whether the left side, right side, or both sides were equally swollen. The evaluation was performed by 3 independent assessors.
Time frame: At 48 hours and 1 week after the end of intervention
Surgical filed visibility
Fromme-Boezaart scale 0 = No bleeding (cadaveric conditions) 1. = Slight bleeding - no suction required 2. = Slight bleeding - occasional suctioning required 3. = Slight bleeding - frequent suctioning required; bleeding threatens surgical field a few seconds after suction is removed 4. = Moderate bleeding - frequent suctioning required and bleeding threatens surgical field directly after suction is removed 5. = Severe bleeding - constant suctioning required; bleeding appears faster than can be removed by suction; surgical field severely
Time frame: Intraoperatively
Headaches (Adverse events of tranexamic acid)
Patient reported outcome using a questionnaire interview And clinical examination (0=no,1=yes)
Time frame: within one week after end of the intervention
Nausea vomiting (Adverse events of tranexamic acid)
Patient reported outcome using a questionnaire interview And clinical examination (0=no,1=yes)
Time frame: within one week after end of the intervention
Seizure (Adverse events of tranexamic acid)
Patient reported outcome using a questionnaire interview And clinical examination (0=no,1=yes)
Time frame: within one week after end of the intervention
Thromboembolic events (Adverse events of tranexamic acid)
Patient reported outcome using a questionnaire interview And clinical examination (0=none,1=DVT,2=Stroke,3=MI)
Time frame: within one week after end of the intervention
Drug allergy (Adverse events of tranexamic acid)
Patient reported outcome using a questionnaire interview And clinical examination (0=no,1=yes : urticaria, MP rash, anaphylaxis)
Time frame: within one week after end of the intervention
Local irritation
Patient reported outcome using a questionnaire interview And clinical examination (0=no,1=yes : rash, erythema, itching)
Time frame: within one week after end of the intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.